directCHECK whole blood control labeled with incorrect performance range
directCHECK ACT-LR whole blood quality control, level 2, is being recalled because the assayed control carries labeling with an incorrect performance range. 6,060 units affected.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall for an incorrect printed performance range with no clinical consequence described in the source, which fits the Moderate labeling band.
Plain-English summary
The directCHECK ACT-LR whole blood quality control, level 2, model/catalog number DCGLR-2, UDI 10711234170373, is being recalled. The action covers 6,060 units in lot A6DLA001.
The stated reason is that the assayed whole blood control contains labeling with an incorrect performance range. The FDA classified the action as Class II. The source does not describe a resulting clinical consequence.
Distribution was worldwide, including nationwide in the United States across a large number of states. The controls are supplied to laboratories rather than sold to consumers.
Laboratories should identify affected stock using the catalog number, UDI and lot number above and follow the instructions issued by the manufacturer.
The recalled product
- Product
- directCHECK ACT-LR whole blood quality control, level 2 Model/Catalog Number: DCGLR-2
- Manufacturer
- Accriva Diagnostics, Inc.
- Affected units
- 6,060
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: A6DLA001 Unique Device Identifier: 10711234170373
Distribution
Related recalls
Same manufacturer · Accriva Diagnostics, Inc.
See all →- HighClotting time test cuvettes recalled over a sharp-edged foreign object
FDA (Devices) · 2025-12-10
- ModeratePlatelet reactivity tests recalled after an uncleared device was distributed
FDA (Devices) · 2025-11-19
- HighVerifyNow P2Y12 Platelet Reactivity Test distributed without FDA market clearance
FDA (Devices) · 2025-01-22
- HighBlood Oximeter Calibration Error Causes Inaccurate Oxygen Readings
FDA (Devices) · 2024-11-06
- HighUnclearred VerifyNow P2Y12 Platelet Test Variant Distributed to Healthcare Providers
FDA (Devices) · 2022-06-01
Same hazard · labeling error
See all →- ModerateLiquid Hope Organic Meal Replacement Formula Subpotent Vitamin A Recall
FDA (Food) · 2026-07-22
- ModerateOrthofix MINIRAIL external fixation devices recalled for incorrect model labeling
FDA (Devices) · 2026-07-22
- Moderate
- HighPerampanel Prescription Tablets Recalled for Labeling Mix-up
FDA (Drugs) · 2026-07-01
- HighAdndale magnesium glycinate gummies contain undeclared melatonin in three lots
FDA (Food) · 2026-06-24